ACHE and Alzheimer disease: Notably, some species of Amaryllidaceae produce the alkaloid galanthamine, which was isolated for the first time from Galanthus woronowii in the 1950s, and at the beginning of this century was approved for the treatment of mild to moderate stages of AD being a competitive AChE inhibitor with modulatory properties towards nicotinic ACh receptors [24].